Literature DB >> 7555962

Effects of the anticonvulsant losigamone and its isomers on the GABAA receptor system.

W Dimpfel1, S S Chatterjee, M Nöldner, M K Ticku.   

Abstract

We conducted in vitro studies to clarify the possible involvement of GABAA receptor-mediated processes in the anticonvulsant effects of losigamone and its optical isomers AO-242 (+ losigamone) and AO-294 (- losigamone). In binding experiments with cortical and cerebellar membrane preparations of rat brain, < or = 100 microM losigamone did not affect the specific binding of [3H]GABA, [3H]flunitrazepam, or [35S]t-butyl-bicyclophosphorothionate (TBPS) to their receptors. Losigamone, however, in concentrations of 10(-8)-10(-5) M, stimulated 36Cl influx into spinal cord neurons in the absence of exogenous GABA. This effect was inhibited by the GABA antagonists bicuculline (BIC) and picrotoxin (PIC). Losigamone 10(-5) M potentiated the effect of a suboptimal concentration of exogenous GABA 10(-5) M on 36 Cl influx. Both isomers of losigamone likewise stimulated 36Cl influx into spinal cord neurons, and these effects were similarly antagonized by BIC and PIC. Losigamone and its optical isomers AO-294 and AO-242 antagonized potassium-induced hyperexcitability in rat hippocampal slices concentration dependently. There were no clear differences in the potencies of losigamone, AO-242, or AO-294. However, AO-294 and AO-242 differed significantly in their ability to suppress TBPS-induced hyperexcitability of hippocampal slices. Such observations demonstrate that although losigamone does not bind to GABA, benzodiazepine (BZD) or PIC binding sites of the neuronal chloride channel, it is capable of stimulating 36Cl influx in the spinal cord neurons by a GABA-sensitive mechanism and at a side distant from the GABA channel.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7555962     DOI: 10.1111/j.1528-1157.1995.tb00956.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  5 in total

1.  The anticonvulsant effects of the enantiomers of losigamone.

Authors:  F A Jones; J A Davies
Journal:  Br J Pharmacol       Date:  1999-11       Impact factor: 8.739

2.  Pharmacokinetics of [14C]-labelled Losigamone and enantiomers after oral administration to healthy subjects.

Authors:  P A Peeters; J J Van Lier; N Van De Merbel; B Oosterhuis; J Wieling; J H Jonkman; K Klessing; A Biber
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1998 Jan-Mar       Impact factor: 2.441

Review 3.  Molecular mechanisms of antiseizure drug activity at GABAA receptors.

Authors:  L John Greenfield
Journal:  Seizure       Date:  2013-05-14       Impact factor: 3.184

Review 4.  Losigamone add-on therapy for focal epilepsy.

Authors:  Yousheng Xiao; Man Luo; Jin Wang; Hongye Luo
Journal:  Cochrane Database Syst Rev       Date:  2018-01-22

5.  Losigamone add-on therapy for focal epilepsy.

Authors:  Hongchang Chen; Honghu He; Yousheng Xiao; Man Luo; Hongye Luo; Jin Wang
Journal:  Cochrane Database Syst Rev       Date:  2019-12-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.